News
Hosted on MSN3mon
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600mMerck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio in a $600m (€500m) deal. The move aims to enhance Merck’s ...
Germany’s Merck KGaA has agreed to acquire Mirus Bio, a specialist in transfection reagents used in the production of cell and gene therapies (CGTs), in a deal valued at around $600 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback